XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net loss $ (188,632) $ (67,395)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Non-cash interest expense 5,664 11,447
Depreciation and amortization expense 65,757 51,409
Stock-based compensation expense 46,773 49,723
Non-cash lease expense 11,405 8,644
Provision for credit losses 4,610 3,551
Loss on debt extinguishment 0 1,101
Gain on sale of investment 0 (27,875)
Impairment charges 58,782 0
Other 2,920 1,759
Changes in operating assets and liabilities, net of assets and liabilities acquired:    
Accounts receivable, net (6,632) (58,847)
Other receivables, net (2,790) (14,738)
Prepaid expenses and other assets 2,585 (1,030)
Accounts payable and accrued expenses 3,484 15,888
Deferred revenue 45,549 34,697
Other liabilities, net (20,831) (10,528)
Net cash provided by (used in) operating activities 28,644 (2,194)
Cash flows from investing activities    
Purchase of a business, net of cash acquired 5,010 0
Additions of amortizable intangible assets (34,854) (29,867)
Purchases of property and equipment (5,218) (2,452)
Purchase of investment 0 (1,000)
Proceeds from sale of investment 0 37,875
Advances made to university clients (310) 0
Advances repaid by university clients 200 200
Other (7) 56
Net cash (used in) provided by investing activities (35,179) 4,812
Cash flows from financing activities    
Proceeds from debt 385 469,595
Payments on debt (3,793) (703)
Payment of debt issuance costs 0 (10,258)
Tax withholding payments associated with settlement of restricted stock units (1,741) (14,114)
Proceeds from exercise of stock options 892 4,270
Proceeds from employee stock purchase plan share purchases 1,282 1,773
Net cash (used in) provided by financing activities (2,975) 450,563
Effect of exchange rate changes on cash (2,614) (713)
Net (decrease) increase in cash, cash equivalents and restricted cash (12,124) 452,468
Cash, cash equivalents and restricted cash, beginning of period 249,909 518,866
Cash, cash equivalents and restricted cash, end of period $ 237,785 $ 971,334